Dr. Reddy’s Laboratories has reappointed Prasad G V as Co-Chairman and Managing Director for a new five-year term starting January 30, 2026. The appointment was endorsed by shareholders during the company’s 41st Annual General Meeting, reflecting strong confidence in Prasad’s strategic leadership and vision for the firm’s future.
As a promoter and influential board member, Prasad has been instrumental in transforming Dr. Reddy’s into a global pharmaceutical powerhouse. “Prasad has played a crucial role in positioning Dr. Reddy’s as a global pharmaceutical leader with a focus on innovation and expansion.” His guidance has been central to the company’s growth strategy, helping expand its global presence and enhancing its reputation in the competitive pharmaceutical landscape.
Prasad’s leadership extends beyond Dr. Reddy’s, with key roles in academia and industry organizations. He currently serves on the boards of prestigious institutions such as the Indian School of Business and Ashoka University. Additionally, he chairs the CII National Committee on Pharmaceuticals and holds the honorary position of Consul of Belgium in Hyderabad. These roles underscore his broad influence and commitment to advancing both industry and education.
Educationally, Prasad holds a Chemical Engineering degree from the Illinois Institute of Technology and a master’s in Industrial Administration from Purdue University, combining technical expertise with strong managerial acumen.
His reappointment signals the company’s confidence in his ability to steer Dr. Reddy’s through evolving challenges while continuing to prioritize innovation and international expansion. “The decision, approved by shareholders at the company’s 41st Annual General Meeting, reflects strong confidence in his strategic leadership.”
Under Prasad’s stewardship, Dr. Reddy’s Laboratories is expected to maintain its trajectory of growth and continue playing a key role in the global pharmaceutical industry.
